Clinical trial
Utilizing 18F-fluoroglutamine PET Imaging in Patients With Pulmonary Arterial Hypertension
NCT05452889 is registered in ClinicalTrials.gov with Stephen Y. Chan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utilizing 18F-fluoroglutamine PET Imaging in Patients With Pulmonary Arterial Hypertension
- Lead sponsor
- Stephen Y. Chan
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- July 11, 2022
- Completion date
- February 28, 2027
- Enrollment
- 71 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.